Spoken Alpha
DTIL
PRECISION BIOSCIENCES INC
Overview
PRECISION BIOSCIENCES INC is a Healthcare company operating in Biotechnology with a $194.7M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 1, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-10-04.
Transcripts
Recent earnings calls
No earnings calls indexed for DTIL yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add DTIL, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q3 FY20262026-11-01EPS— vs $-1.02—Rev— vs ——EODHD
- Q2 FY20262026-08-05EPS$-0.71 vs $-0.74+4.0%Rev$0 vs ——EODHD
- Q1 FY20262026-05-04EPS$-0.75 vs $-0.81+7.4%Rev$10.8M vs ——EODHD
- Q4 FY20252026-03-11EPS$1.01 vs $-0.64+100.0%Rev$34.2M vs ——EODHD
- Q3 FY20252025-11-02EPS$-1.84 vs $-2.21+16.7%Rev$13.0K vs ——EODHD
- Q2 FY20252025-08-06EPS$-2.13 vs $-0.09-100.0%Rev$18.0K vs ——EODHD
- Q1 FY20252025-05-14EPS$-2.21 vs $-0.43-100.0%Rev$29.0K vs ——EODHD
- Q4 FY20242025-03-24EPS$-2.14 vs $-2.94+27.5%Rev$638.0K vs ——EODHD
- Q3 FY20242024-11-03EPS$-2.25 vs $-3.13+28.1%Rev$576.0K vs ——EODHD
- Q2 FY20242024-07-31EPS$4.67 vs $-5.07+100.0%Rev$49.9M vs ——EODHD
- Q1 FY20242024-05-12EPS$1.70 vs $-1.91+100.0%Rev$17.6M vs ——EODHD
- Q4 FY20232024-03-26EPS$-4.06 vs $-2.05-98.0%Rev$7.0M vs ——EODHD
- Q3 FY20232023-11-06EPS$-2.10 vs $-5.00+58.0%Rev$13.1M vs ——EODHD
- Q2 FY20232023-08-03EPS$-3.00 vs $-7.50+60.0%Rev$19.8M vs ——EODHD
- Q1 FY20232023-05-08EPS$-6.55 vs $-6.60+0.8%Rev$8.8M vs ——EODHD
- Q4 FY20222023-03-08EPS$-0.26 vs $-0.21-23.8%Rev$10.6M vs ——EODHD
- Q3 FY20222022-11-07EPS$-6.60 vs $-11.16+40.9%Rev$7.4M vs ——EODHD
- Q2 FY20222022-08-07EPS$-13.80 vs $-13.92+0.9%Rev$3.8M vs ——EODHD
- Q1 FY20222022-05-08EPS$-13.80 vs $-16.20+14.8%Rev$3.3M vs ——EODHD
- Q4 FY20212022-03-14EPS$-0.52 vs $-0.47-10.6%Rev$6.3M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-01 | — | $-1.02 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $-0.71 | $-0.74 | +4.0% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-04 | $-0.75 | $-0.81 | +7.4% | $10.8M | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $1.01 | $-0.64 | +100.0% | $34.2M | — | — | EODHD |
| Q3 FY2025 | 2025-11-02 | $-1.84 | $-2.21 | +16.7% | $13.0K | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-2.13 | $-0.09 | -100.0% | $18.0K | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-2.21 | $-0.43 | -100.0% | $29.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-24 | $-2.14 | $-2.94 | +27.5% | $638.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-03 | $-2.25 | $-3.13 | +28.1% | $576.0K | — | — | EODHD |
| Q2 FY2024 | 2024-07-31 | $4.67 | $-5.07 | +100.0% | $49.9M | — | — | EODHD |
| Q1 FY2024 | 2024-05-12 | $1.70 | $-1.91 | +100.0% | $17.6M | — | — | EODHD |
| Q4 FY2023 | 2024-03-26 | $-4.06 | $-2.05 | -98.0% | $7.0M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-2.10 | $-5.00 | +58.0% | $13.1M | — | — | EODHD |
| Q2 FY2023 | 2023-08-03 | $-3.00 | $-7.50 | +60.0% | $19.8M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-6.55 | $-6.60 | +0.8% | $8.8M | — | — | EODHD |
| Q4 FY2022 | 2023-03-08 | $-0.26 | $-0.21 | -23.8% | $10.6M | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $-6.60 | $-11.16 | +40.9% | $7.4M | — | — | EODHD |
| Q2 FY2022 | 2022-08-07 | $-13.80 | $-13.92 | +0.9% | $3.8M | — | — | EODHD |
| Q1 FY2022 | 2022-05-08 | $-13.80 | $-16.20 | +14.8% | $3.3M | — | — | EODHD |
| Q4 FY2021 | 2022-03-14 | $-0.52 | $-0.47 | -10.6% | $6.3M | — | — | EODHD |
Source: EODHD. DTIL reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Michael AmorosoCEO5 yr 1 mono recorded callsCurrent
- John Alexander KellyCFO5 yr 5 mono recorded callsCurrent
- J Jefferson SmithChief Research Officer4 yr 2 mono recorded callsCurrent
- Dario ScimecaGeneral Counsel and Secretary6 yr 9 mono recorded callsCurrent
- Fayaz KhaziCEO2 yr 3 mono recorded callsFormer
- Matthew R KaneCEO2 yr 3 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for DTIL.
$ curl https://api.spokenalpha.com/v1/companies/DTILFAQ
Frequently asked about DTIL
Where can I find PRECISION BIOSCIENCES INC's (DTIL) earnings call transcripts?
Spoken Alpha indexes DTIL's earnings call transcripts at https://spokenalpha.com/companies/DTIL. Each call links to attributed speakers and parsed analyst Q&A. PRECISION BIOSCIENCES INC's own investor relations page is at https://precisionbiosciences.com/investors-media/.
What sector is DTIL in?
PRECISION BIOSCIENCES INC (DTIL) operates in the Healthcare sector (Biotechnology industry).